2019
DOI: 10.1093/eurheartj/ehz423
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Implications of the 2017 ACC/AHA Hypertension Guidelines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Moreover, a major shift from 2003 JNC7 guideline is the highest absolute increase proportion of hypertension grade II and highest increase rate of hypertension grade III using the new de nition of hypertension grades. As pharmacologic treatment is recommended for hypertension grade I only if one accompanied with 10-year ASCVD risk ≥ 10% 9 , the 2017 ACC/AHA guideline may has signi cant implication for hypertension treatment population, especially among adults with hypertension grade II and III. In addition, another major shift from 2003 JNC7 guideline is the obviously increasing of the proportion of IDH and SDH among all adults with hypertension.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, a major shift from 2003 JNC7 guideline is the highest absolute increase proportion of hypertension grade II and highest increase rate of hypertension grade III using the new de nition of hypertension grades. As pharmacologic treatment is recommended for hypertension grade I only if one accompanied with 10-year ASCVD risk ≥ 10% 9 , the 2017 ACC/AHA guideline may has signi cant implication for hypertension treatment population, especially among adults with hypertension grade II and III. In addition, another major shift from 2003 JNC7 guideline is the obviously increasing of the proportion of IDH and SDH among all adults with hypertension.…”
Section: Discussionmentioning
confidence: 99%
“…The 2017 ACC/AHA hypertension guideline recommends using a systolic BP (SBP) ≥ 130 mmHg or a diastolic BP (DBP) ≥ 80 mmHg to de ne hypertension, in contrast to a SBP ≥ 140 mmHg or DBP ≥ 90 mmHg that was used to de ne hypertension in guideline of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) in 2003 7 . This major shift has major implications for an entity known as isolated systolic hypertension (ISH), isolated diastolic hypertension (IDH), systolic-diastolic hypertension (SDH), Stage 1 hypertension and Stage 2 hypertension 8, 9 .…”
Section: Introductionmentioning
confidence: 99%
“…For proper management of hypertension, pharmacological and non-pharmacological interventions are needed (4). Among non-pharmacologic therapies, following dietary approach to stop hypertension (DASH) is emphasized as primary interventions for all adults with increased blood pressure (5).…”
Section: Introductionmentioning
confidence: 99%
“…For proper management of hypertension, pharmacological and non-pharmacological interventions are needed(4). Among non-pharmacologic therapies, following dietary approach to stop hypertension (DASH) is emphasized as primary interventions for all adults with increased blood pressure (5).…”
Section: Introductionmentioning
confidence: 99%